MRC1 and cancer: However, it is still unclear whether MBD4 alterations are due to the genomic instability, e.g. are secondary to a MMR defect without having functional consequences on the tumor mutational landscape, or can contribute to the mutator phenotype separately from the MMR defect, conferring a growth advantage to cancer cells.